Intensity-Modulated Radiation Therapy News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Summaries: International Kidney Cancer Symposium
Conclusion: there is no increased risk of doing the lymph node dissection early on. Dr. Eggener-CON Basics Lymph node dissections rarely done, even for large tumors, because there is no proven therapeutic or staging benefit for low risk patients. A Mayo study revealed no data showing therapeutic benefit in high risk patients. For clinically node negative high risk patients, there is staging value but no proven therapeutic benefit. Rate of positive nodes is associated with stage and grade; the higher the stage and grade, the more likely there will be positive nodes. A tumor> 10 cm w...
Source: Kidney Cancer Association - November 29, 2011 Category: Urology & Nephrology Source Type: news

Siemens 200th PRIMUS Linear Accelerator Will Ship to St. Elizabeth Health Center
The Oncology Care Systems Group of Siemens Medical Systems today announced it is shipping the 200th Siemens PRIMUS -- a medical linear accelerator with the ability to deliver Intensity Modulated Radiation Therapy (IMRT) -- to St. Elizabeth Health Center ' s new Radiation Oncology Center in Boardman, OH. (Source: Medical Design Online News)
Source: Medical Design Online News - January 1, 1996 Category: Medical Equipment Source Type: news